Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


This Article
Full Text
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Schroeder, E. T.
Articles by Sattler, F. R.
PubMed
PubMed Citation
Articles by Schroeder, E. T.
Articles by Sattler, F. R.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:1586-1592 (2005)
© 2005 The Gerontological Society of America

Six-Week Improvements in Muscle Mass and Strength During Androgen Therapy in Older Men

E. Todd Schroeder1,2,, Alberto F. Vallejo1,3, Ling Zheng3, Yolanda Stewart3, Carla Flores3, Susie Nakao3, Carmen Martinez3 and Fred R. Sattler1,2,3

1 Department of Biokinesiology and Physical Therapy, 2 Department of Medicine, Division of Infectious Diseases, and 3 General Clinical Research Center of the Keck School of Medicine, University of Southern California, Los Angeles.

Address correspondence to E. Todd Schroeder, PhD, University of Southern California, Departments of Medicine and Biokinesiology & Physical Therapy, 1540 East Alcazar St. CHP-155, Los Angeles, CA 90089. E-mail: eschroed{at}usc.edu

Background. The purpose of our study was to assess the early effects of a potent anabolic androgen on muscle mass and strength, lower extremity power, and functional performance in older men.

Methods. Thirty-two men 72 ± 6 years of age were randomized to receive oxandrolone (10 mg twice daily) or matching placebo in a 2:1 manner for 12 weeks. Total and appendicular lean body mass (LBM) were assessed by dual-energy x-ray absorptiometry (DEXA). Lower extremity muscle volume was determined by magnetic resonance imaging to validate DEXA changes.

Results. Total LBM increased by 2.7 ± 1.6 kg after 6 weeks with oxandrolone (p <.001), which was greater (p <.001) than the decline in LBM (–0.5 ± 0.9 kg) with placebo. Appendicular LBM increased by 1.2 ± 0.9 kg after just 6 weeks with oxandrolone (p <.001), which was greater (p <.001) than the decline in LBM (–0.4 ± 0.5 kg) with placebo. These changes were >90% of the gains in total and appendicular LBM (3.0 ± 1.5 kg and 1.3 ± 0.9 kg, respectively) after 12 weeks. Total thigh and hamstring muscle volume increased by 111 ± 29 mm3 (p =.001) and 75 ± 18 mm3 (p =.001), respectively, after 12 weeks. Maximal strength increased for the leg press 6.3 ± 5.6% (p =.003), leg curl 6.7 ± 8.6% (p =.01), chest press 6.9 ± 6.5% (p =.001), and latissimus pull-down 4.8 ± 6.3% (p =.009) with oxandrolone after 6 weeks; these increases were different than those with placebo (p <.001) and were 93%, 96%, 74%, and 94% of the respective gains at week 12. There were no improvements in functional measures.

Conclusion. Treatment with a potent anabolic androgen may produce significant increases in muscle mass and strength after only 6 weeks in healthy older men. However, such treatment did not improve leg muscle power or walking speed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2005 by The Gerontological Society of America.